Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

Media Mention

Dorothy Whelan Quoted in Law360 Article, “Biologic Fights Drive PTAB Drug Challenges To Record High”

February 8, 2018

Media Mention

Dorothy Whelan Quoted in Law360 Article, “Biologic Fights Drive PTAB Drug Challenges To Record High”

February 8, 2018

Back to News Listing

Dorothy Whelan, Principal and Post-Grant Practice Co-Chair was quoted in Law360’s article, “Biologic Fights Drive PTAB Drug Challenges To Record High” on February 8, 2017.

“When you look at the filers, a lot of them remain generic drug manufacturers,” said Dorothy Whelan, a principal at Fish & Richardson and one of the contributors to the report. “There’s another group that’s smaller but growing, and that’s in the biosimilars area.”

To view the full article please click here.

Click here to access Fish’s 2017 Post-Grant Report.


The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Related Attorneys
Related Services